Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,756.00
Bid: 1,753.00
Ask: 1,754.00
Change: -19.00 (-1.07%)
Spread: 1.00 (0.057%)
Open: 1,770.00
High: 1,770.00
Low: 1,740.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Markets boosted by earnings, Eurozone PMIs

Wed, 24th Jul 2013 11:23

Upbeat corporate earnings from a number of heavyweights and improving data in the Eurozone gave UK markets a boost on Wednesday morning, as traders shrugged off concerns about manufacturing activity in China.easyJet, ARM Holdings, Tate & Lyle, Kingfisher and Compass were all trading firmly higher after results or trading updates this morning. Meanwhile, figures from blue chips Daimler, Volvo and Alstom also impressed over in Europe.In economic data, the Eurozone purchasing managers' indices (PMIs) for both the services and manufacturing sectors beat expectations in July, pushing the composite PMI from 48.7 to 50.4, well ahead of the 49.1 consensus forecast. This was the best reading of private-sector activity in 18 months."Sure, unemployment remains frighteningly high, political instability keeps the market on its toes and deep austerity will be biting hard for some time, but services and manufacturing facets of the Eurozone economy are turning a page," said Market Strategist Ishaq Siddiqi from ETX Capital.Markets were also digesting comments from Goldman Sachs analysts who said they see a near 50% probability that the Monetary Policy Committee will modify its stance at the August meeting. The most likely change would be a cut in the Bank rate or remuneration rate on bank reserves, but additional quantitative easing looks less likely. Chinese data disappointsHSBC's flash China manufacturing PMI fell from 48.2 to 47.7 in July, missing expectations of no change. "Under normal circumstances, this would weigh heavily on investor sentiment and therefore risk assets, such as the European indices, however that is not the case this morning," said Market Analyst Craig Erlam from Alpari.Downside risks to growth were tempered yesterday by the country's Premier Li Keqiang who assured that the pace of expansion would not fall below the "bottom line" of 7.0% this year, indicating that any slowdown would be met with more stimulus."This should limit the short-term negativity surrounding poor Chinese data because it seems for now that growth is guaranteed to remain at these higher levels," Erlam said.FTSE 100: Updates from heavyweights impresseasyJet surged this morning after the budget airline achieved a 10.5% rise in third-quarter revenue to £1.14bn, bolstered by an increase in capacity and growth in revenue per seat. Chip designer ARM Holdings was also on the rise after delivering better-than-expected second-quarter sales and profits. The company also said that dollar revenues would be "at least in line" with market expectations.Food ingredients firm Tate & Lyle gained after saying that adjusted profits were in line with expectations in spite of tough weather conditions in the States in the first quarter.Foodservice and support services company Compass rose after saying expectations for the full year remain "positive and unchanged" following a strong third quarter.Kingfisher, the DIY retail group behind B&Q and Screwfix, said it is on track to hit expectations for the first half after a pick-up in activity in the second quarter, causing shares to rise.Pharmaceuticals giant GlaxoSmithKline was trading higher this morning ahead of its results out this afternoon.Exchange operator London Stock Exchange was subdued after going ex-dividend. Engineering and project management group AMEC was trading lower after HSBC downgraded the stock to 'neutral' and cut its target price from 1,200p to 1,130p.FTSE 100 - RiserseasyJet (EZJ) 1,439.00p +7.71%ARM Holdings (ARM) 940.50p +4.73%Glencore Xstrata (GLEN) 292.40p +3.43%Weir Group (WEIR) 2,173.00p +2.89%Tate & Lyle (TATE) 847.00p +2.85%International Consolidated Airlines Group SA (CDI) (IAG) 293.90p +2.80%Travis Perkins (TPK) 1,720.00p +2.69%Antofagasta (ANTO) 875.50p +2.16%Melrose Industries (MRO) 273.60p +1.90%TUI Travel (TT.) 371.00p +1.87%FTSE 100 - FallersMeggitt (MGGT) 538.00p -1.65%Croda International (CRDA) 2,421.00p -1.14%British Land Co (BLND) 610.00p -1.13%BG Group (BG.) 1,198.00p -1.03%Sage Group (SGE) 356.00p -0.84%Hammerson (HMSO) 533.50p -0.56%Amec (AMEC) 1,066.00p -0.56%Hargreaves Lansdown (HL.) 1,006.00p -0.40%Barclays (BARC) 320.45p -0.40%Fresnillo (FRES) 1,088.00p -0.28%FTSE 250 - RisersImagination Technologies Group (IMG) 269.20p +7.38%Wetherspoon (J.D.) (JDW) 708.00p +5.99%National Express Group (NEX) 259.00p +5.50%Hochschild Mining (HOC) 171.60p +4.63%Mitchells & Butlers (MAB) 433.30p +4.41%Bumi (BUMI) 225.00p +3.93%Premier Farnell (PFL) 228.40p +3.12%Dialight (DIA) 1,221.00p +3.04%Playtech (PTEC) 706.50p +2.39%St. Modwen Properties (SMP) 308.80p +2.18%FTSE 250 - FallersBeazley (BEZ) 215.90p -4.34%TalkTalk Telecom Group (TALK) 246.80p -2.06%Renishaw (RSW) 1,535.00p -2.04%Kier Group (KIE) 1,395.00p -1.97%Man Group (EMG) 86.15p -1.94%Chemring Group (CHG) 301.00p -1.67%Carpetright (CPR) 666.00p -1.62%Great Portland Estates (GPOR) 577.50p -1.45%Anite (AIE) 130.00p -1.44%Barr (A.G.) (BAG) 562.00p -1.23%BC
More News
16 Oct 2023 07:16

GSK nears green light for Jemperli usage in Europe

(Sharecast News) - Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer - paving the way for marketing authorisation by the continent's regulatory body.

Read more
11 Oct 2023 11:51

GSK settles California Zantac lawsuit

(Sharecast News) - GSK has agreed to settle another lawsuit concerning its discontinued heartburn treatment Zantac, the drugs giant confirmed on Wednesday.

Read more
11 Oct 2023 09:17

LONDON BROKER RATINGS: JPMorgan raises Croda; Berenberg cuts Atalaya

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
11 Oct 2023 08:51

LONDON MARKET OPEN: FTSE 100 higher; Travis Perkins warns on profit

(Alliance News) - Stock prices in London opened largely higher on Wednesday as market mood remained resilient, despite the continuing conflict in the Middle East, amid a softening of rhetoric from the US central bank.

Read more
11 Oct 2023 08:36

TOP NEWS: GSK reaches settlement for Zantac litigation in California

(Alliance News) - GSK PLC on Wednesday said that it has reached a confidential settlement in the Cantlay/Harper case, which alleged that the firm's heartburn medication can cause cancer.

Read more
11 Oct 2023 07:47

LONDON BRIEFING: Stocks lower; GSK settles Zantac case in California

(Alliance News) - Stocks in London are set to open lower on Wednesday as investor looked ahead to the release of the US Federal Reserve's September meeting minutes later in the day.

Read more
9 Oct 2023 08:16

TOP NEWS: GSK inks agreement with Zhifei to promote shingles vaccine

(Alliance News) - GSK PLC on Monday said it has reached an exclusive agreement with Chongqing Zhifei Biological Products Ltd to co-promote its shingles vaccine, Shingrix, in China.

Read more
9 Oct 2023 07:42

LONDON BRIEFING: Metro Bank secures deal to shore up finances

(Alliance News) - Stocks in London are set to open higher on Monday as interest rate expectations held steady despite Friday's bumper US nonfarm payrolls report.

Read more
9 Oct 2023 07:20

GSK inks deal to promote shingles vaccine in China

(Sharecast News) - GSK has entered into a new exclusive vaccine partnership in China that will extend the availability of its shingle vaccine Shingrix, which will see the UK-listed group generate £2.5bn over the next three years.

Read more
8 Oct 2023 11:36

Sunday newspaper round-up: Renewi, Metro Bank, New homes

(Sharecast News) - Some of Renewi's major shareholders are divided as to whether the recycling company should engage with Australian suitor Macquarie. One major shareholder has told Renewi's board that it should not until Macquarie raised its £636m bid, but another top ten shareholder told The Sunday Times that it should talk to the Australian outfit anyways. Macquarie has until 26 October to make a firm offer. - The Sunday Times

Read more
6 Oct 2023 08:17

GSK raises £885.6m from Haleon share sale

(Sharecast News) - GSK said on Friday that it has sold 270m shares in Haleon - the consumer health business it spun off last year - raising around £885.6m.

Read more
6 Oct 2023 07:57

UPDATE: GSK banks GBP886 million from Haleon share sale

(Alliance News) - GSK PLC on Friday said it received GBP885.6 million in gross proceeds from its sale of shares in consumer healthcare spin-off Haleon PLC.

Read more
6 Oct 2023 07:46

LONDON BRIEFING: Wetherspoon swings to profit; UK house prices fall

(Alliance News) - Stocks in London are called to open higher on Friday, as investors eye a key nonfarm payroll reading in the US.

Read more
5 Oct 2023 15:47

UK dividends calendar - next 7 days

Friday 6 October 
Admiral Group PLCdividend payment date
Alfa Financial Software Holdings PLCspecial dividend payment date
Anglo-Eastern Plantations PLCdividend payment date
Blackrock World Mining Trust PLCdividend payment date
Cairn Homes PLCdividend payment date
Dalata Hotel Group PLCdividend payment date
Drax Group PLCdividend payment date
Glanbia PLCdividend payment date
GlobalData PLCdividend payment date
Goodwin PLCdividend payment date
Greggs PLCdividend payment date
Intertek Group PLCdividend payment date
Irish Continental Group PLCdividend payment date
JPMorgan American Investment Trust PLCdividend payment date
JPMorgan Global Growth & Income PLCdividend payment date
Land Securities Group PLCdividend payment date
Personal Assets Trust PLCdividend payment date
Quartix Technologies PLCdividend payment date
Serco Group PLCdividend payment date
Walker Crips Group PLCdividend payment date
Warehouse REIT PLCdividend payment date
Zotefoams PLCdividend payment date
Monday 9 October 
Henderson Smaller Cos Investment Trust PLCdividend payment date
LondonMetric Property PLCdividend payment date
Tuesday 10 October 
LSL Property Services PLCdividend payment date
Wednesday 11 October 
Assura PLCdividend payment date
Rathbones Group PLCdividend payment date
Thursday 12 October 
Blackrock Latin American Investment Trust PLCex-dividend payment date
Breedon Group PLCex-dividend payment date
Diageo PLCdividend payment date
GSK PLCdividend payment date
Howden Joinery Group PLCex-dividend payment date
i3 Energy PLCex-dividend payment date
Invesco Bond Income Plus Ltdex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
JPMorgan Mid Cap Investment Trust PLCex-dividend payment date
Kingfisher PLCex-dividend payment date
MP Evans Group PLCex-dividend payment date
Macfarlane Group PLCdividend payment date
North American Income Trust PLCex-dividend payment date
Oxford Instruments PLCdividend payment date
Persimmon PLCex-dividend payment date
Personal Group Holdings PLCex-dividend payment date
Primary Health Properties PLCex-dividend payment date
Ruffer Investment Co Ltdex-dividend payment date
Senior PLCex-dividend payment date
Spirax-Sarco Engineering PLCex-dividend payment date
Strategic Equity Capital PLCex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
Taylor Wimpey PLCex-dividend payment date
Tesco PLCex-dividend payment date
TT Electronics PLCdividend payment date
WPP PLCex-dividend payment date
XP Power Ltddividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
3 Oct 2023 18:19

IN BRIEF: GSK's Jemperli approved in UK for endometrial cancer

GSK PLC - London-based pharmaceutical company - On Monday, announces that the UK Medicines & Health Products Regulatory Agency has authorised a new indication for Jemperli, also known as dostarlimab. The drug is used as a treatment for some types of endometrial cancer and an be used to treat patients that have a tumour abnormality called mismatch repair deficient/microsatellite instability-high when the cancer is at an advanced stage when first diagnosed or has returned after previous treatment. It is now authorised to be used together with chemotherapy to slow the progression of these cancers. GSK says it is the first medicine licensed as first line treatment for primary advanced or recurrent endometrial cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.